233 results on '"Goyal, Omesh"'
Search Results
2. Print versus pixels: Who’s winning the tug-of-war?
3. Normative values of skeletal muscle mass, strength and performance in the Indian population
4. AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study
5. Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology
6. Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC)
7. Quality of life in Indian patients with functional dyspepsia: Translation and validation of the Hindi version of Short-Form Nepean Dyspepsia Index
8. THU-078 Extra-hepatic organ failure in ACLF patients is associated with poor survival and limited curative therapy-results from AARC cohort
9. THU-052 Therapeutic plasma-exchange improves short-term survival in patients with ACLF admitted to intensive care unit with organ failures-a multinational AARC data analysis
10. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India
11. Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial.
12. Author’s reply to comment on the article: Psychological issues in patients with irritable bowel syndrome: Throwing more light is necessary
13. Muscle strength and physical performance, rather than muscle mass, correlate with mortality in end-stage liver disease
14. Muscle strength and physical performance, rather than muscle mass, correlate with mortality in end-stage liver disease
15. Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study
16. Do Hepatic Fibrosis and Steatosis Measured by Hepatic Transient Elastography (FibroScan) Predict Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease: An Observational Cross-sectional Study.
17. Minimal Hepatic Encephalopathy in Cirrhosis- How Long to Treat?
18. Indian consensus on chronic constipation in adults: A joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology
19. Change in nomenclature and definition from NAFLD to MASLD maintains the disease severity determining association between type 2 DM and MASLD - The results of multi-centre Indian Consortium on MASLD (ICOM-D)
20. A Multicentre Double Blind, Placebo Controlled Randomized Trial to Evaluate the Safety and Efficacy of Bovine Colostrum in the Treatment of Severe Alcoholic Hepatitis (SAH).
21. Optimal Duration of Pegylated Interferon Plus Ribavirin Therapy for Chronic Hepatitis C Genotype 3 Patients who do not Achieve Rapid Virological Response
22. Esophageal motility disorders—Symptomatic and manometric spectrum in Punjab, northern India
23. New paradigms in management of alcoholic hepatitis: a review
24. Treatment of chronic hepatitis C genotype 3 with Sofosbuvir-based therpy: a real-life study
25. Methodological Aspects of “Thoracoabdominal Wall Motion–Guided Biofeedback Treatment of Abdominal Distention: A Randomized Placebo-Controlled Trial”
26. Evaluation of a fixed-dose combination of mebeverine and chlordiazepoxide for irritable bowel syndrome
27. AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study
28. Reply
29. L‐ornithine L‐aspartate in bouts of overt hepatic encephalopathy
30. FRI-231 Compared to complete abstainers, non-significant alcohol use may be associated with more severe liver disease in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)-The multicentre study of the indian consortium on MASLD
31. HCC surveillance results in earlier HCC detection: results from an Indian cohort
32. Treatment of chronic hepatitis C with pegylated interferon plus ribavirin in treatment-naïve ‘real-life’ patients in India
33. Skin and soft tissue infections in cirrhotics: A prospective analysis of clinical presentation and factors affecting outcome
34. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy
35. Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India
36. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols dietversustraditional dietary advice for functional dyspepsia: a randomized controlled trial
37. Corticosteroid Plus Pentoxifylline Is Not Better than Corticosteroid Alone for Improving Survival in Severe Alcoholic Hepatitis (COPE Trial)
38. Improvement in health related quality of life in cirrhotics with minimal hepatic encephalopathy after treatment: a prospective, randomized trial comparing rifaximin and lactulose: O-037
39. Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea‐predominant irritable bowel syndrome: A prospective, randomized trial
40. Gastrointestinal and Hepatic Manifestations of Dengue Infection
41. Bacterial Hepatitis
42. Su1504 THE ALBI SCORE IS NOT ACCURATE FOR PREDICTING SHORT-TERM MORTALITY IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE
43. 9 BASELINE AMMONIA LEVELS PREDICT MORTALITY AND LIVER-RELATED COMPLICATIONS IN ACUTE-ON-CHRONIC LIVER FAILURE PATIENTS
44. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India
45. The Practice of Gastrointestinal Motility Laboratory During COVID-19 Pandemic: Position Statements of the Asian Neurogastroenterology and Motility Association (ANMA-GML-COVID-19 Position Statements)
46. Validation of AGILE-4 Score for Assessing Cirrhosis in Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD): An Interim Analysis of the Multicentric Indian Consortium on Nafld (ICON D) Study
47. Validation of AGILE-3+ Score for Assessing Advanced Fibrosis in Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD): An Interim Analysis of the Multicentric Indian Consortium on NAFLD (ICON D) Study
48. Predictive Scores for Mortality in MAFLD-Related Acute-on-Chronic Liver Failure (MAFLD-ACLF): Development and Validation of MAFLD-MELD-Na and MAFLD-AARC Scores.
49. Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease.
50. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet versus traditional dietary advice for functional dyspepsia: a randomized controlled trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.